Browse medicines
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Medicine type
Approval status
AllApproved in the United States (FDA)Approved in the European Union (EMA)In Phase 3 testingIn Phase 2 testingUsed in a way not covered by an approval, or made by a compounding pharmacyDietary supplement; not FDA-approved as a medicineFDA accelerated approval (based on an earlier result expected to predict benefit; follow-up evidence may be required)Laboratory or animal-stage researchControlled substance; no approved US useWithdrawn from the market
Amount of information
Showing 1–3 of 3 records
Epitalon (Also written Epithalon and AEDG peptide. Distinct from Epithalamin, the bovine pineal extract it was derived from)
Peptide medicineLaboratory or animal-stage researchDetailed recordUse listed on the medicine record
A four-amino-acid anti-ageing peptide with no clinical trial anywhere
Betiatide (Technetium Tc 99m Mertiatide / Kit For the Preparation of Technetium Tc99m Mertiatide / Technescan Mag3)
Peptide medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
The diagnosis of congenital and acquired renal abnormalities, renal failure, urinary tract obstruction, and calculi
Bulevirtide (Hepcludex)
Peptide medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Chronic hepatitis delta virus (HDV) infection